HSK42360

Other Medications

Description

Detailed description is being prepared by our clinical team.

Clinical Trials

NCT07561554 Phase 1
Recruiting
Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation
China
NCT06536400 Phase 1
Recruiting
Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation
China